Peptide education
Carnosine
L-carnosine · beta-alanyl-L-histidine
Carnosine is a naturally occurring dipeptide made from beta-alanine and L-histidine. It is present in skeletal muscle and appears in some skin products and oral supplements.
Topical carnosine changed markers of oxidative stress and glycation in laboratory skin samples. Those findings do not establish sunscreen protection or an appearance benefit in people.
Overview
Quick answer
Experiments on skin removed from the body, studies of oral supplements, and trials of a finished cosmetic answer different questions. Results from one setting cannot simply be assigned to another.
What is carnosine?
It is a two-amino-acid molecule composed of beta-alanine and L-histidine. Carnosine occurs in skeletal muscle and is studied in several different product and research contexts.
What does the topical skin research show?
In excised human skin exposed to simulated sunlight, topical carnosine reduced markers of reactive oxygen species and advanced glycation products. The experiment did not measure sun protection in people.
Is carnosine a sunscreen?
The cited skin-explant experiment did not establish sunscreen effectiveness in people. In the United States, sunscreen products are regulated as drugs because of their intended protective use.
Has oral carnosine been studied in people?
Yes. A small randomized study gave oral carnosine or placebo to adults with prediabetes or type 2 diabetes and measured glucose responses. Those oral results do not establish an effect from a skin cream.
Evidence
Evidence snapshot
Researchers applied carnosine to excised human skin and measured oxidative stress and glycation markers after simulated solar exposure.
A separate study tested aqueous carnosine and a carnosine-containing cream on explants from one donor under chemically induced glycation.
A 14-week trial measured glucose tolerance after oral carnosine or placebo. Of 49 eligible for enrollment and randomization, 43 completed the study. It did not test skin appearance.
Cosmetic and drug categories depend on the product's intended use; general cosmetic rules do not establish the safety of a particular formulation.
Claims
Common claims vs evidence
| Claim | Human evidence | Mechanistic evidence | Verdict |
|---|---|---|---|
| Carnosine reduces oxidative stress markers in human skin samples. | The cited study used excised human skin maintained in a laboratory, not a trial of people applying a commercial product. | Under simulated radiation, treated samples showed lower measured reactive oxygen species and glycation-product markers. | Supported in that ex-vivo model, without establishing a clinical skin benefit. |
| A carnosine cream prevents sunburn or replaces sunscreen. | The cited tissue experiment did not test prevention of sunburn or clinical sunscreen performance in people. | That conclusion does not follow from the laboratory measurements. | |
| Carnosine is always a cosmetic and never a drug. | Carnosine has been studied both in topical products and as an oral supplement. FDA classifies a finished product according to its intended use. | Classification cannot be determined from the ingredient name alone. | |
| Oral metabolic findings prove a topical skin effect. | The randomized oral study measured glucose responses, not the effect of a carnosine cream on skin. | No. Route, formulation, population, and outcome differ. |
Bottom line
Main takeaway
Carnosine is a small peptide found in the body. Some skin experiments are promising, but they were done on tissue samples rather than people.
A laboratory solution, a finished cream, and a capsule have different ingredients, routes, and evidence. A tissue marker is not a sunscreen test.
Reactive oxygen species and glycation markers in explants are mechanistic outcomes. The oral study measured glucose tolerance in a separate population.
Identity
What it is
Carnosine consists of beta-alanine linked to L-histidine. It occurs in skeletal muscle; supplementing a precursor is not the same intervention as administering carnosine itself.
A skin experiment tested topical solutions on biopsied tissue, while a separate randomized trial administered carnosine by mouth to people with prediabetes or type 2 diabetes.
Use context
Routes, doses, and cycle patterns
Topical research includes controlled laboratory applications to excised tissue. Oral supplementation has been studied separately in people.
Human studies and product labels
Simulated-sunlight skin experiment
- Context
- Excised human skin in laboratory culture
- Route
- Topical application to tissue samples
- Amount
- 0.2% and 2% carnosine solutions
The measurements were taken in a laboratory model, not a clinical trial of sunburn prevention or a finished sunscreen.
Skin glycation experiment
- Context
- Excised skin from one human donor with chemically induced glycation
- Route
- Topical application to tissue samples
- Amount
- Aqueous solution and a cream each containing 0.2% carnosine
Each treatment and control condition used three explants. The cream contained other ingredients. The endpoint was glycation-marker staining, not a clinical wrinkle outcome.
Oral glucose metabolism trial
- Context
- Adults with prediabetes or type 2 diabetes
- Route
- Oral
- Amount
- 1 g per dose, totaling 2 g per day
- Frequency
- Twice daily
- Duration
- 14 weeks
The trial measured glucose after an oral glucose tolerance test. It did not study a topical formulation or establish long-term clinical outcomes.
Research
Research evidence
In an oral supplementation study of adults with prediabetes or type 2 diabetes, 49 were eligible for enrollment and randomization and 43 completed the trial: 20 in the carnosine group and 23 in the placebo group. The skin studies used tissue samples, not clinical treatment of participants' skin.
| Study / evidence area | Population | Design | Product context | Main outcome | Limitations | Weight |
|---|---|---|---|---|---|---|
| Oral glucose metabolism trial | 49 adults with prediabetes or type 2 diabetes eligible for enrollment and randomization; 43 completed the trial | Randomized, placebo-controlled trial over 14 weeks | Oral carnosine 1 g twice daily, totaling 2 g per day, or placebo | The investigators reported lower glucose values at selected points in an oral glucose tolerance test and no significant change in insulin levels. | The small study included adults with prediabetes or type 2 diabetes. It did not test skin outcomes or establish long-term effects on diabetes complications. | Limited human evidence for an oral metabolic outcome |
Cautions
Safety and unknowns
- Skin explants cannot show how often a finished product causes irritation or allergy in people. Safety depends on the full formulation and use.
- The oral glucose study was small and lasted 14 weeks. It did not establish long-term safety or a replacement for established diabetes care.
- The skin-explant results do not demonstrate protection against sunburn or skin cancer in people. An antioxidant claim is not a clinical sunscreen test.
Mechanism
How it is proposed to work
In laboratory models, carnosine can influence measures of oxidative stress and glycation. The relevance of those measurements to visible skin changes requires clinical testing.
The simulated-sunlight experiment measured reactive oxygen species and advanced glycation products in treated skin explants.
A separate explant study induced glycation chemically and measured selected products in skin after treatment with carnosine-containing preparations. Results from a multicomponent cream do not isolate every ingredient's contribution.
Beta-alanine is a precursor used in studies of muscle carnosine. That is a separate intervention from oral or topical carnosine.
Details
Technical details
Sources
References
- 1.
PubMed. L-carnosine and solar-simulated radiation in human skin explants
doi:10.1111/php.13850 PMID:37675862
Laboratory study of excised skin, not a clinical sunscreen study.
- 2.
PubMed. Carnosine and glycation markers in human skin explants
doi:10.1159/000492276 PMID:30199874
Ex-vivo laboratory study comparing aqueous carnosine and a multicomponent cream.
- 3.
PubMed. Oral carnosine and glucose metabolism in adults: randomized controlled trial
doi:10.1016/j.numecd.2023.10.012 PMID:38172006
Small oral supplementation study in adults with prediabetes or type 2 diabetes.
- 4.
PubMed. Histidine and beta-alanine supplementation and muscle carnosine
doi:10.1249/MSS.0000000000001213 PMID:28106620
Describes the dipeptide's components and its presence in skeletal muscle.
- 5.
FDA. FDA guidance on cosmetic and drug classification
Product classification depends on intended use; cosmetic rules include exceptions and safety responsibilities.
- 6.
Other. Oral carnosine and glucose metabolism: published trial full text
doi:10.1016/j.numecd.2023.10.012 PMID:38172006
Published trial details the divided dose and participant disposition.